(Q45153282)

10 December 2017

Epidemiological study of hospitalization associated with respiratory syncytial virus infection in Taiwanese children between 2004 and 2007. (English)

1 reference

10 December 2017

1 reference

Luan-Yin Chang

7

0 references

Li-Min Huang

object named as

Li-Min Huang

4

0 references

Pei-Lan Shao

5

object named as

Pei-Lan Shao

1 reference

10 December 2017

Hsin Chi

1

1 reference

10 December 2017

I-Shou Chang

2

1 reference

10 December 2017

Fang-Yu Tsai

3

1 reference

10 December 2017

Nan-Chang Chiu

6

1 reference

10 December 2017

Fu-Yuan Huang

8

1 reference

10 December 2017

1 June 2011

1 reference

Journal of the Formosan Medical Association

10 December 2017

1 reference

10 December 2017

110

1 reference

10 December 2017

388-396

1 reference

10 December 2017

6

1 reference

Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality

10 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Respiratory syncytial virus and parainfluenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

RSV infection in infants and young children. What's new in diagnosis, treatment, and prevention?

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Respiratory Syncytial Virus: Update on Infection, Treatment, and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Annual variation in respiratory syncytial virus season and decisions regarding immunoprophylaxis with palivizumab

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Optimization strategy to minimize wastage of palivizumab during the 2008 RSV season in São Paulo, Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Respiratory viral infections among pediatric inpatients and outpatients in Taiwan from 1997 to 1999

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Epidemiology of respiratory syncytial virus infection among paediatric inpatients in northern Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

The burden of respiratory syncytial virus infection in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Cost, causes and rates of rehospitalization of preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2811%2960057-0

7 January 2021

Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD000181.PUB2

Identifiers

DOI

10.1016/S0929-6646(11)60057-0

1 reference

10 December 2017

1 reference